Founda Health Holding B.V. – Trademark Portfolio
Entity Type: 99
Founda Health Holding B.V. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FOUNDA HEALTH. The owner is based in Amsterdam.
Postjesweg 1
Amsterdam 1057DT , NL
Showing of trademarks Trademarks
Trademark Classifications
Founda Health Holding B.V.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Founda Health Holding B.V. have?
Founda Health Holding B.V. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Founda Health Holding B.V. file in?
Founda Health Holding B.V. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are Founda Health Holding B.V.'s most well-known trademarks?
Founda Health Holding B.V.'s registered trademark portfolio includes well-known marks such as FOUNDA HEALTH. These are among 2 currently registered trademarks in the portfolio.
What is Founda Health Holding B.V.'s trademark registration success rate?
Founda Health Holding B.V. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.